In a previous study, reduced fatty acid desaturase 1 (FADS1) function was related to NAFLD and responded to treatment in children through FADS1 transcription levels (Nobili et al., 2018). The gene discussed is FADS1; the disease is metabolic dysfunction-associated steatotic liver disease.